Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

187 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Callister SM, et al. Among authors: schell rf. J Infect Dis. 1993 Jan;167(1):158-64. doi: 10.1093/infdis/167.1.158. J Infect Dis. 1993. PMID: 8418162
Detection of borreliacidal antibodies by flow cytometry.
Callister SM, Jobe DA, Schell RF. Callister SM, et al. Among authors: schell rf. Curr Protoc Cytom. 2004 Nov;Chapter 11:Unit 11.5. doi: 10.1002/0471142956.cy1105s26. Curr Protoc Cytom. 2004. PMID: 18770791
Borrelia-primed and -infected mice deficient of interleukin-17 develop arthritis after neutralization of gamma-interferon.
Kuo J, Warner TF, Schell RF. Kuo J, et al. Among authors: schell rf. Pathog Dis. 2017 Mar 1;75(2). doi: 10.1093/femspd/ftx014. Pathog Dis. 2017. PMID: 28175297
Arthritis is inhibited in Borrelia-primed and infected interleukin-17A-deficient mice after administration of anti-gamma-interferon, anti-tumor necrosis factor alpha and anti-interleukin-6 antibodies.
Kuo J, Warner TF, Schell RF. Kuo J, et al. Among authors: schell rf. Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx073. Pathog Dis. 2017. PMID: 28859307
Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.
Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. Kuo J, et al. Among authors: schell rf. Clin Vaccine Immunol. 2011 Jul;18(7):1125-32. doi: 10.1128/CVI.00052-11. Epub 2011 May 25. Clin Vaccine Immunol. 2011. PMID: 21613457 Free PMC article.
Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF. LaFleur RL, et al. Among authors: schell rf. Clin Vaccine Immunol. 2009 Feb;16(2):253-9. doi: 10.1128/CVI.00373-08. Epub 2008 Dec 3. Clin Vaccine Immunol. 2009. PMID: 19052162 Free PMC article.
Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Amlong CA, et al. Among authors: schell rf. Clin Vaccine Immunol. 2006 Feb;13(2):289-96. doi: 10.1128/CVI.13.2.289-296.2006. Clin Vaccine Immunol. 2006. PMID: 16467340 Free PMC article.
Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
Munson EL, Nardelli DT, Luk KH, Remington MC, Callister SM, Schell RF. Munson EL, et al. Among authors: schell rf. Clin Vaccine Immunol. 2006 Jan;13(1):19-25. doi: 10.1128/CVI.13.1.19-25.2006. Clin Vaccine Immunol. 2006. PMID: 16425995 Free PMC article.
Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD, Jobe DA, Schell RF, Callister SM. Lovrich SD, et al. Among authors: schell rf. Clin Diagn Lab Immunol. 2005 Jun;12(6):746-51. doi: 10.1128/CDLI.12.6.746-751.2005. Clin Diagn Lab Immunol. 2005. PMID: 15939749 Free PMC article.
Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Munson EL, DeCoster DJ, Nardelli DT, England DM, Callister SM, Schell RF. Munson EL, et al. Among authors: schell rf. Clin Diagn Lab Immunol. 2004 Jan;11(1):35-41. doi: 10.1128/cdli.11.1.35-41.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715542 Free PMC article.
187 results
Jump to page
Feedback